Quest Diagnostics's market cap is currently $20.27B. The company's EPS TTM is $2.6; its P/E ratio is 21.38; and it has a dividend yield of 1.75%. Quest Diagnostics is scheduled to report earnings on October 21, 2025, and the estimated EPS forecast is $2.37. See an overview of income statement, balance sheet, and cash flow financials.
